ArticleScientific reports2025
Diagnosis of diabetes without oral glucose tolerance test is associated with increased mortality in older adults.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Residual coronary atherosclerotic risk and low LDL-cholesterol in chronic coronary syndromes.European heart journal. Imaging methods and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The current method of diagnosing diabetes mellitus (DM) using fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) without oral glucose tolerance tests (OGTT) results in inaccuracy and underdiagnosis of diabetes. This study aimed to investigate the mortality of individuals with improperly classified glycemic status and suggest new screening methods for diabetes. A total of 1935 subjects were prospectively followed for 10 years, with vital status obtained through linkage to the National Health Insurance Research Database (NHIRD). Hazard ratios (HR) of all-cause mortality were analyzed. The percentage of all-cause mortality was significantly higher in subjects with improperly classified glycemic status than those correctly classified (8.3% vs. 3.6%, p = 0.004; unadjusted HR 2.537, p = 0.002). The risk of mortality associated with underdiagnosis was highest in those over the age of 60 (adjusted HR 2.043, p = 0.036). Using components of metabolic syndrome, three screening strategies were developed to determine the need for OGTT in elderly subjects with improved sensitivity in diagnosing DM. Diagnosis of diabetes based solely on FPG and HbA1c leads to underdiagnosis of glycemic status and higher all-cause mortality in older adults. Age and the presence of components of metabolic syndrome-based screening strategies can improve diagnostic accuracy and reduce the need for OGTT.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.